Logo image of AAN

AARON'S CO INC/THE (AAN) Stock Fundamental Analysis

NYSE:AAN - New York Stock Exchange, Inc. - US00258W1080 - Common Stock - Currency: USD

10.09  +0.1 (+1%)

After market: 10.09 0 (0%)

Fundamental Rating

3

AAN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 120 industry peers in the Specialty Retail industry. AAN has a bad profitability rating. Also its financial health evaluation is rather negative. AAN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year AAN has reported negative net income.
AAN had a positive operating cash flow in the past year.
In multiple years AAN reported negative net income over the last 5 years.
In the past 5 years AAN always reported a positive cash flow from operatings.
AAN Yearly Net Income VS EBIT VS OCF VS FCFAAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

AAN's Return On Assets of -2.40% is in line compared to the rest of the industry. AAN outperforms 41.80% of its industry peers.
AAN has a Return On Equity of -6.47%. This is comparable to the rest of the industry: AAN outperforms 49.18% of its industry peers.
Industry RankSector Rank
ROA -2.4%
ROE -6.47%
ROIC N/A
ROA(3y)2.5%
ROA(5y)-2.14%
ROE(3y)4.98%
ROE(5y)-3.82%
ROIC(3y)N/A
ROIC(5y)N/A
AAN Yearly ROA, ROE, ROICAAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30

1.3 Margins

In the last couple of years the Profit Margin of AAN has declined.
AAN's Operating Margin has declined in the last couple of years.
AAN has a better Gross Margin (52.53%) than 80.33% of its industry peers.
AAN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.53%
OM growth 3Y-44.69%
OM growth 5Y-28.43%
PM growth 3YN/A
PM growth 5Y-45.82%
GM growth 3Y-5.74%
GM growth 5Y-2.88%
AAN Yearly Profit, Operating, Gross MarginsAAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

AAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AAN has been reduced compared to 1 year ago.
Compared to 5 years ago, AAN has less shares outstanding
AAN has a better debt/assets ratio than last year.
AAN Yearly Shares OutstandingAAN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M
AAN Yearly Total Debt VS Total AssetsAAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

AAN has an Altman-Z score of 0.96. This is a bad value and indicates that AAN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AAN (0.96) is worse than 77.87% of its industry peers.
AAN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
AAN has a Debt to Equity ratio of 0.31. This is comparable to the rest of the industry: AAN outperforms 53.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 0.96
ROIC/WACCN/A
WACC9.27%
AAN Yearly LT Debt VS Equity VS FCFAAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.30 indicates that AAN may have some problems paying its short term obligations.
AAN's Current ratio of 0.30 is on the low side compared to the rest of the industry. AAN is outperformed by 96.72% of its industry peers.
A Quick Ratio of 0.19 indicates that AAN may have some problems paying its short term obligations.
With a Quick ratio value of 0.19, AAN is not doing good in the industry: 89.34% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.19
AAN Yearly Current Assets VS Current LiabilitesAAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

2

3. Growth

3.1 Past

AAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -132.41%.
The earnings per share for AAN have been decreasing by -42.94% on average. This is quite bad
The Revenue has decreased by -8.73% in the past year.
AAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.58% yearly.
EPS 1Y (TTM)-132.41%
EPS 3YN/A
EPS 5Y-42.94%
EPS Q2Q%-117.95%
Revenue 1Y (TTM)-8.73%
Revenue growth 3Y7.24%
Revenue growth 5Y3.58%
Sales Q2Q%-5.14%

3.2 Future

Based on estimates for the next years, AAN will show a very negative growth in Earnings Per Share. The EPS will decrease by -20.60% on average per year.
AAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.34% yearly.
EPS Next Y-102.06%
EPS Next 2Y-14.44%
EPS Next 3Y-13.93%
EPS Next 5Y-20.6%
Revenue Next Year-3.08%
Revenue Next 2Y-0.18%
Revenue Next 3Y0.99%
Revenue Next 5Y1.34%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AAN Yearly Revenue VS EstimatesAAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
AAN Yearly EPS VS EstimatesAAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

AAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AAN is valuated rather expensively with a Price/Forward Earnings ratio of 17.23.
Based on the Price/Forward Earnings ratio, AAN is valued a bit cheaper than the industry average as 63.93% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, AAN is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 17.23
AAN Price Earnings VS Forward Price EarningsAAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

AAN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AAN is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.98
AAN Per share dataAAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as AAN's earnings are expected to decrease with -13.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.44%
EPS Next 3Y-13.93%

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.96%, AAN is a good candidate for dividend investing.
AAN's Dividend Yield is rather good when compared to the industry average which is at 5.15. AAN pays more dividend than 94.26% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, AAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.96%

5.2 History

AAN has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
AAN Yearly Dividends per shareAAN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

The earnings of AAN are negative and hence is the payout ratio. AAN will probably not be able to sustain this dividend level.
DP-36.48%
EPS Next 2Y-14.44%
EPS Next 3Y-13.93%
AAN Yearly Income VS Free CF VS DividendAAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M -200M

More info and screens

AARON'S CO INC/THE

NYSE:AAN (10/3/2024, 8:04:00 PM)

After market: 10.09 0 (0%)

10.09

+0.1 (+1%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-05 2024-08-05/amc
Earnings (Next)10-21 2024-10-21/amc
Inst Owners87.86%
Inst Owner Change-6.59%
Ins Owners3.68%
Ins Owner Change0%
Market Cap318.34M
Analysts51.43
Price Target10.28 (1.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.96%
Yearly Dividend0.49
Dividend Growth(5Y)N/A
DP-36.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-185.44%
Min EPS beat(2)-266.32%
Max EPS beat(2)-104.57%
EPS beat(4)0
Avg EPS beat(4)-336.25%
Min EPS beat(4)-887.96%
Max EPS beat(4)-86.14%
EPS beat(8)4
Avg EPS beat(8)-44.8%
EPS beat(12)8
Avg EPS beat(12)-17.65%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.69%
Min Revenue beat(2)-3.4%
Max Revenue beat(2)-1.98%
Revenue beat(4)0
Avg Revenue beat(4)-2.9%
Min Revenue beat(4)-3.4%
Max Revenue beat(4)-1.98%
Revenue beat(8)1
Avg Revenue beat(8)-1.86%
Revenue beat(12)3
Avg Revenue beat(12)-0.86%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.75%
EPS NQ rev (1m)-14.72%
EPS NQ rev (3m)-29.58%
EPS NY rev (1m)0%
EPS NY rev (3m)-113.14%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)-1.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.23
P/S 0.15
P/FCF N/A
P/OCF 5.39
P/B 0.48
P/tB 0.64
EV/EBITDA 0.98
EPS(TTM)-0.47
EYN/A
EPS(NY)0.59
Fwd EY5.8%
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)1.87
OCFY18.57%
SpS65.6
BVpS20.85
TBVpS15.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.4%
ROE -6.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.53%
FCFM N/A
ROA(3y)2.5%
ROA(5y)-2.14%
ROE(3y)4.98%
ROE(5y)-3.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.13%
ROCE(5y)9.77%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-44.69%
OM growth 5Y-28.43%
PM growth 3YN/A
PM growth 5Y-45.82%
GM growth 3Y-5.74%
GM growth 5Y-2.88%
F-Score4
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 0.4
Cap/Depr 17.59%
Cap/Sales 4.5%
Interest Coverage N/A
Cash Conversion 11.62%
Profit Quality N/A
Current Ratio 0.3
Quick Ratio 0.19
Altman-Z 0.96
F-Score4
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)17.01%
Cap/Depr(5y)15.28%
Cap/Sales(3y)4.75%
Cap/Sales(5y)4.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-132.41%
EPS 3YN/A
EPS 5Y-42.94%
EPS Q2Q%-117.95%
EPS Next Y-102.06%
EPS Next 2Y-14.44%
EPS Next 3Y-13.93%
EPS Next 5Y-20.6%
Revenue 1Y (TTM)-8.73%
Revenue growth 3Y7.24%
Revenue growth 5Y3.58%
Sales Q2Q%-5.14%
Revenue Next Year-3.08%
Revenue Next 2Y-0.18%
Revenue Next 3Y0.99%
Revenue Next 5Y1.34%
EBIT growth 1Y-143.99%
EBIT growth 3Y-40.69%
EBIT growth 5Y-25.86%
EBIT Next Year380.41%
EBIT Next 3Y83.29%
EBIT Next 5Y47.46%
FCF growth 1Y-220.09%
FCF growth 3Y-33.07%
FCF growth 5Y-6.35%
OCF growth 1Y-55.53%
OCF growth 3Y-20.26%
OCF growth 5Y-0.66%